Fig. 2: Day-of-injury blood biomarker concentrations among those without and with probable PTSD at 6-month outcome. | Neuropsychopharmacology

Fig. 2: Day-of-injury blood biomarker concentrations among those without and with probable PTSD at 6-month outcome.

From: Association of day-of-injury plasma glial fibrillary acidic protein concentration and six-month posttraumatic stress disorder in patients with mild traumatic brain injury

Fig. 2

a (top): Day-of-injury plasma GFAP concentrations among those without (“no”) and with (“yes”) probable PTSD at 6-month outcome. b (bottom): Day-of-injury serum hsCRP concentrations among those without (“no”) and with (“yes”) probable PTSD at 6-month outcome post-injury.

Back to article page